scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1092049275 |
P356 | DOI | 10.1186/S12933-017-0606-7 |
P8608 | Fatcat ID | release_4xvq2hbybzh3reoiry6ezinhja |
P932 | PMC publication ID | 5625702 |
P698 | PubMed publication ID | 28969633 |
P2093 | author name string | Atsushi Hirayama | |
Shigemasa Tani | |||
Tsukasa Yagi | |||
Wataru Atsumi | |||
Kenji Kawauchi | |||
Rei Matsuo | |||
P2860 | cites work | Common medications used by patients with type 2 diabetes mellitus: what are their effects on the lipid profile? | Q26740253 |
Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association | Q28235865 | ||
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins | Q29547856 | ||
Low-density lipoprotein subfractions and the long-term risk of ischemic heart disease in men: 13-year follow-up data from the Québec Cardiovascular Study | Q30979271 | ||
Is ischemia the only factor predicting cardiovascular outcomes in all diabetes mellitus patients? | Q33582307 | ||
Triglycerides and small dense LDL: the twin Achilles heels of the Friedewald formula | Q34270559 | ||
Effect of fenugreek on hyperglycaemia and hyperlipidemia in diabetes and prediabetes: A meta-analysis | Q34536586 | ||
Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes | Q34673134 | ||
Measurement of small dense low-density lipoprotein particles | Q36154957 | ||
Clinical importance and therapeutic modulation of small dense low-density lipoprotein particles | Q36675450 | ||
Atherogenic dyslipidemia and risk of silent coronary artery disease in asymptomatic patients with type 2 diabetes: a cross-sectional study. | Q37119482 | ||
Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies | Q37172727 | ||
Changes in triglycerides and high-density lipoprotein cholesterol may precede peripheral insulin resistance, with 2-h insulin partially mediating this unidirectional relationship: a prospective cohort study | Q37394438 | ||
Effects of rosuvastatin versus atorvastatin on small dense low-density lipoprotein: a meta-analysis of randomized trials | Q38104228 | ||
Postprandial hypertriglyceridemia as a coronary risk factor | Q38186473 | ||
Revised equations for estimated GFR from serum creatinine in Japan | Q39513402 | ||
Low-density lipoprotein cholesterol to apolipoprotein B ratio is independently associated with metabolic syndrome in Korean men. | Q39784759 | ||
Relationship of the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio to the remainder of the lipid profile: The Very Large Database of Lipids-4 (VLDL-4) study | Q40671676 | ||
Usefulness of the LDL-C/apoB ratio in the overall evaluation of atherogenicity of lipid profile | Q40680512 | ||
Diabetes and cardiovascular disease. The Framingham study | Q41509493 | ||
Predictive value of serum apolipoprotein B/LDL-cholesterol ratio in cardiometabolic risk: Population-based cohort study | Q42917836 | ||
Association of triglyceride-rich lipoproteins-related markers and low-density lipoprotein heterogeneity with cardiovascular risk: effectiveness of polyacrylamide-gel electrophoresis as a method of determining low-density lipoprotein particle size | Q43683403 | ||
Assessment of LDL Particle Size by Triglyceride/HDL-Cholesterol Ratio in Non-diabetic,Healthy Subjects without Prominent Hyperlipidemia | Q44621125 | ||
Effect of dipeptidyl peptidase-4 inhibitor, vildagliptin on plasminogen activator inhibitor-1 in patients with diabetes mellitus. | Q51308633 | ||
Apolipoprotein B metabolism and the distribution of VLDL and LDL subfractions | Q73462749 | ||
Lowering the triglyceride/high-density lipoprotein cholesterol ratio is associated with the beneficial impact of pioglitazone on progression of coronary atherosclerosis in diabetic patients: insights from the PERISCOPE (Pioglitazone Effect on Regres | Q83144004 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | lipoprotein | Q28350 |
triglyceride | Q186319 | ||
coronary artery disease | Q844935 | ||
type 2 diabetes | Q3025883 | ||
P304 | page(s) | 123 | |
P577 | publication date | 2017-10-02 | |
P1433 | published in | Cardiovascular Diabetology | Q2468083 |
P1476 | title | Relation between low-density lipoprotein cholesterol/apolipoprotein B ratio and triglyceride-rich lipoproteins in patients with coronary artery disease and type 2 diabetes mellitus: a cross-sectional study | |
P478 | volume | 16 |
Q54996163 | Cardiovascular disease risk factor responses to a type 2 diabetes care model including nutritional ketosis induced by sustained carbohydrate restriction at 1 year: an open label, non-randomized, controlled study. |
Q90364685 | Could remnant-like particle cholesterol become a risk factor in diabetic menopausal women with coronary artery disease? A cross-sectional study of single academic center in China |
Q91757726 | Elevated triglycerides rather than other lipid parameters are associated with increased urinary albumin to creatinine ratio in the general population of China: a report from the REACTION study |
Q90698756 | Impact of free fatty acids on prognosis in coronary artery disease patients under different glucose metabolism status |
Q64897581 | Investigation into Lipid Management in Acute Coronary Syndrome Patients from the EXPLORE-J Study. |
Q61443208 | Remnant lipoproteins play an important role of in-stent restenosis in type 2 diabetes undergoing percutaneous coronary intervention: a single-centre observational cohort study |
Q64112606 | Serum triglycerides as a risk factor for cardiovascular diseases in type 2 diabetes mellitus: a systematic review and meta-analysis of prospective studies |
Search more.